Evaluation of Blood Flow Characteristics in Glaucoma Using Optical Coherence Tomography Angiography (OCT-A).

NCT02757677 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-05-10

No results posted yet for this study

Summary

The investigators aim to evaluate the efficacy of the new Optical Coherence Tomography based Angiography (OCT-A) softwares in the diagnosis and management of glaucoma.

Conditions

Interventions

DEVICE

Optical Coherence Tomography based Angiography

A contrast-free, noninvasive technology to identify blood vessels in the eye

Sponsors & Collaborators

  • Swiss Vision Network

    lead OTHER

Principal Investigators

  • Kaweh Mansouri, MD · Glaucoma center, Montchoisi clinic, Swiss vision network

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02757677 on ClinicalTrials.gov